戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 the efficacy of three different prokaryotic (Achromobacter, Agrobacterium and Bacillus) EPSPS genes.
2             The opportunistic human pathogen Achromobacter (Alcaligenes) xylosoxidans has been recove
3             Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans have been incre
4   Scanning electron microscopy revealed that Achromobacter and Stenotrophomonas formed a biofilm on t
5 ia were prevalent in all disease groups, and Achromobacter and Stenotrophomonas were present in one a
6                                    The genus Achromobacter currently is comprised of seven species, i
7 tica (Pn) nitrous oxide reductase (N2OR) and Achromobacter cycloclastes (Ac) N2OR and its relevance t
8 ture of the pink-purple species of N2OR from Achromobacter cycloclastes (AcN2OR) isolated under aerob
9 characterized members of the Pseudomonas and Achromobacter genera.
10  scheme, we analyzed 107 genetically diverse Achromobacter isolates cultured from biologic specimens
11  investigations, to clarify the taxonomy of "Achromobacter-like" strains, and to elucidate the popula
12 se IV to the lysine-specific endoprotease of Achromobacter lyticus suggested three possible disulfide
13 served in the related beta-lytic protease of Achromobacter lyticus.
14                                              Achromobacter piechaudii strain HLE is a betaproteobacte
15 yses of taxonomically related Bordetella and Achromobacter species also indicated the presence of an
16 lusters confirmed the seven previously named Achromobacter species and revealed 14 additional genogro
17                                              Achromobacter species possess a Vi antigen-specific depo
18 er known species that were detected included Achromobacter spp., Afipia spp., Brevundimonas diminuta,
19  sequence analysis was more likely to detect Achromobacter, Stenotrophomonas, and Burkholderia, it wa
20                                              Achromobacter, Stenotrophomonas, and Delftia were predom
21                                              Achromobacter, Stenotrophomonas, and Delftia were preval
22  who were culture positive for Burkholderia, Achromobacter, Stenotrophomonas, and Ralstonia clustered
23 trains, plus three recently genome-sequenced Achromobacter strains, were assigned to 129 sequence typ
24 sent in soil bacteria belonging to the genus Achromobacter Vi antigen assembly follows a widespread g
25 hogen was the most common with pan-resistant Achromobacter xylosoxidans (100%) followed by MDR Stenot
26  MDR Stenotrophomonas maltophilia (46%), MDR Achromobacter xylosoxidans (33%), and finally, pan-resis
27 tant Achromobacter xylosoxidans (n = 9), MDR Achromobacter xylosoxidans (n = 15), pan-resistant Steno
28 ts were divided into 5 groups: pan-resistant Achromobacter xylosoxidans (n = 9), MDR Achromobacter xy
29 nickel resistance loci on plasmid pTOM9 from Achromobacter xylosoxidans 31A, ncc and nre.
30 deria cepacia, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and atypical mycobacteria are
31 th MDR pathogens, specifically pan-resistant Achromobacter xylosoxidans and Stenotrophomonas maltophi
32 res before transplantation were reviewed for Achromobacter xylosoxidans and Stenotrophomonas maltophi
33                         The CF patients with Achromobacter xylosoxidans and Stenotrophomonas maltophi
34 eruginosa, Stenotrophomonas maltophilia, and Achromobacter xylosoxidans but was less sensitive for th
35                                              Achromobacter xylosoxidans is typically isolated from pu
36                                              Achromobacter xylosoxidans Q19 oxidized PQS congeners wi
37                              This yielded an Achromobacter xylosoxidans strain (Q19) that inactivated
38 dependent on copper (Cu) as a cofactor (e.g. Achromobacter xylosoxidans).
39 tly is comprised of seven species, including Achromobacter xylosoxidans, an opportunistic and nosocom
40 altophilia (n = 26), and CF patients without Achromobacter xylosoxidans, Stenotrophomonas maltophilia
41 phomonas maltophilia and 2 patients with MDR Achromobacter xylosoxidans.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。